在ERCP中,急性胆道炎的管理是由于骨破裂引起的
Tiemin Jiang1, Zongding Wang2, Tuerganaili Aji1
1State Key Laboratory of Pathogenesis, Prevention and Management of High Incidence Diseases in Central Asia, The First Clinical Medical College of Xinjiang Medical University; Department of Hepatobiliary and Hydatid Diseases, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
内镜逆行胆血管细胞造影 (ERCP) 有效地管理肝囊性球菌病 (HCE) 的胆道并发症. ERCP改善了患者的病情,并支持后续手术,减少并发症和住院时间.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 手术并发症 手术并发症
背景情况:
- 肝发性囊性赤道球菌 (HCE) 破裂进入胆道是常见的并发症.
- 拉巴切除术是去除水病变的标准治疗方法.
- 在管理这种特定的并发症ERCP的有效性需要调查.
研究的目的:
- 评估ERCP在治疗HCE破裂进入胆道中的作用和有效性.
- 为了比较ERCP治疗后进行手术的患者和仅进行手术治疗的患者之间的结果.
主要方法:
- 追溯分析40名HCE患者的胆道破裂.
- 患者分为ERCP组 (n=14) 和传统手术组 (n=26).
- 在可选腹腔切除术之前,ERCP组接受了ERCP以控制感染;手术组接受了直接腹腔切除术.
主要成果:
- ERCP显著改善了感染参数和肝//凝血功能 (P < 0.05).
- ERCP组显示手术期间出血减少,住院时间缩短 (P < 0.05).
- 术后并发症,包括急性功能衰竭和凝血功能障碍,在ERCP组明显较低 (P<0.05).
结论:
- 在控制感染和改善HCE破裂进入胆道患者的全身状况方面,ERCP是有效的.
- ERCP促进了随后的激进手术,显示出良好的临床应用前景.
- 这种方法在管理复杂的外科并发症时提供了显著的好处.
相关概念视频
Endoscopic Procedures V: ERCP
Patient...
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

